Olmesartan Pediatric Pharmacokinetic (PK) Study - Trial 2015-003328-30

Name: Clinical Trial 2015-003328-30
Creator: Daiichi Sankyo Pharma Development
Keywords: Hypertension, clinical trial

Access comprehensive clinical trial information for 2015-003328-30 through Pure Global AI's free database. This phase not specified trial is sponsored by Daiichi Sankyo Pharma Development and is currently status unknown. The study focuses on Hypertension.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

2015-003328-30

Trial Details

EU Clinical Trials Register • 2015-003328-30

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Olmesartan Pediatric Pharmacokinetic (PK) Study

Study Focus

Disease/Condition

Hypertension

Sponsor & Location

Primary Sponsor

Daiichi Sankyo Pharma Development

Timeline & Enrollment

Phase

N/A

Start Date

N/A

End Date

N/A

Primary Outcome

1. Clinically significant cardiac, gastrointestinal, hematological, hepatic or hepatobiliary, neurological, or pulmonary (except asthma) disorder

ICD-10 Classifications

Hypertensive diseases

Renovascular hypertension

Secondary hypertension

Other secondary hypertension

Hypertensive heart disease

Data Source

Registry

EU Clinical Trials Register

Trial ID

2015-003328-30

Type

Non-Device Trial